182 related articles for article (PubMed ID: 21528084)
1. DEC1 nuclear expression: a marker of differentiation grade in hepatocellular carcinoma.
Shi XH; Zheng Y; Sun Q; Cui J; Liu QH; Qü F; Wang YS
World J Gastroenterol; 2011 Apr; 17(15):2037-43. PubMed ID: 21528084
[TBL] [Abstract][Full Text] [Related]
2. The anti-metastatic effect of 8-MOP on hepatocellular carcinoma is potentiated by the down-regulation of bHLH transcription factor DEC1.
Xiong J; Yang H; Luo W; Shan E; Liu J; Zhang F; Xi T; Yang J
Pharmacol Res; 2016 Mar; 105():121-33. PubMed ID: 26808085
[TBL] [Abstract][Full Text] [Related]
3. The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in gastric cancer.
Zheng Y; Jia Y; Wang Y; Wang M; Li B; Shi X; Ma X; Xiao D; Sun Y
OMICS; 2009 Aug; 13(4):301-6. PubMed ID: 19624270
[TBL] [Abstract][Full Text] [Related]
4. Differentiated embryonic chondrocyte-expressed gene 1 is associated with hypoxia-inducible factor 1α and Ki67 in human gastric cancer.
Jia YF; Xiao DJ; Ma XL; Song YY; Hu R; Kong Y; Zheng Y; Han SY; Hong RL; Wang YS
Diagn Pathol; 2013 Feb; 8():37. PubMed ID: 23445622
[TBL] [Abstract][Full Text] [Related]
5. Dec1 expression predicts prognosis and the response to temozolomide chemotherapy in patients with glioma.
Li XM; Lin W; Wang J; Zhang W; Yin AA; Huang Y; Zhang J; Yao L; Bian H; Zhang J; Zhang X
Mol Med Rep; 2016 Dec; 14(6):5626-5636. PubMed ID: 27840944
[TBL] [Abstract][Full Text] [Related]
6. Differentiated embryo chondrocyte 1 (DEC1) is a novel negative regulator of hepatic fibroblast growth factor 21 (FGF21) in aging mice.
Fujita Y; Makishima M; Bhawal UK
Biochem Biophys Res Commun; 2016 Jan; 469(3):477-82. PubMed ID: 26697751
[TBL] [Abstract][Full Text] [Related]
7. [Expression characteristics of nuclear factor kappa B in hepatocellular carcinoma tissues].
Zhou WM; Ping JL; Qian FC; Zhang GL
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):843-6. PubMed ID: 19958645
[TBL] [Abstract][Full Text] [Related]
8. DEC1 is positively associated with the malignant phenotype of invasive breast cancers and negatively correlated with the expression of claudin-1.
Liu Y; Miao Y; Wang J; Lin X; Wang L; Xu HT; Wang EH
Int J Mol Med; 2013 Apr; 31(4):855-60. PubMed ID: 23426649
[TBL] [Abstract][Full Text] [Related]
9. The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma.
Wilkens L; Jaggi R; Hammer C; Inderbitzin D; Giger O; von Neuhoff N
Virchows Arch; 2011 Jun; 458(6):697-708. PubMed ID: 21484430
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced overexpression of DEC1 is regulated by HIF-1α in hepatocellular carcinoma.
Ma W; Shi X; Lu S; Wu L; Wang Y
Oncol Rep; 2013 Dec; 30(6):2957-62. PubMed ID: 24100543
[TBL] [Abstract][Full Text] [Related]
11. Expression of beta-catenin in hepatocellular carcinoma.
Tien LT; Ito M; Nakao M; Niino D; Serik M; Nakashima M; Wen CY; Yatsuhashi H; Ishibashi H
World J Gastroenterol; 2005 Apr; 11(16):2398-401. PubMed ID: 15832407
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptors (LXRalpha and LXRbeta) are potent regulators for hepatic Dec1 expression.
Noshiro M; Usui E; Kawamoto T; Sato F; Nakashima A; Ueshima T; Honda K; Fujimoto K; Honma S; Honma K; Makishima M; Kato Y
Genes Cells; 2009 Jan; 14(1):29-40. PubMed ID: 19032342
[TBL] [Abstract][Full Text] [Related]
13. Down regulation of differentiated embryonic chondrocytes 1 (DEC1) is involved in 8-methoxypsoralen-induced apoptosis in HepG2 cells.
Peng Y; Liu W; Xiong J; Gui HY; Feng XM; Chen RN; Hu G; Yang J
Toxicology; 2012 Nov; 301(1-3):58-65. PubMed ID: 22796345
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of type II tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma.
Jiang SY; Chou JM; Leu FJ; Hsu YY; Shih YL; Yu JC; Lee MS; Shyu RY
World J Gastroenterol; 2005 Feb; 11(7):948-53. PubMed ID: 15742394
[TBL] [Abstract][Full Text] [Related]
15. Effects of overexpression of basic helix-loop-helix transcription factor Dec1 on osteogenic and adipogenic differentiation of mesenchymal stem cells.
Iwata T; Kawamoto T; Sasabe E; Miyazaki K; Fujimoto K; Noshiro M; Kurihara H; Kato Y
Eur J Cell Biol; 2006 May; 85(5):423-31. PubMed ID: 16487626
[TBL] [Abstract][Full Text] [Related]
16. Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence.
Zulehner G; Mikula M; Schneller D; van Zijl F; Huber H; Sieghart W; Grasl-Kraupp B; Waldhör T; Peck-Radosavljevic M; Beug H; Mikulits W
Am J Pathol; 2010 Jan; 176(1):472-81. PubMed ID: 20008139
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma.
Cui H; Wu F; Sun Y; Fan G; Wang Q
BMC Cancer; 2010 Jul; 10():356. PubMed ID: 20604928
[TBL] [Abstract][Full Text] [Related]
18. Decreased levels of nitric oxide production and nitric oxide synthase-2 expression are associated with the development and metastasis of hepatocellular carcinoma.
Zhou L; Wang Y; Tian DA; Yang J; Yang YZ
Mol Med Rep; 2012 Dec; 6(6):1261-6. PubMed ID: 23007408
[TBL] [Abstract][Full Text] [Related]
19. Association of Low Zinc Finger Antiviral Protein Expression with Progression and Poor Survival of Patients with Hepatocellular Carcinoma.
Liu Y; Hu C; Zhu WB; Xu WX; Li ZY; Lin Y; Cai J; Liang JK; Zhu X; Gao ZL; Yan GM; Peng L
Cell Physiol Biochem; 2018; 49(3):1007-1018. PubMed ID: 30196292
[TBL] [Abstract][Full Text] [Related]
20. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
